๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group

โœ Scribed by Weigel, Brenda; Malempati, Suman; Reid, Joel M.; Voss, Stephan D.; Cho, Steven Y.; Chen, Helen X.; Krailo, Mark; Villaluna, Doojduen; Adamson, Peter C.; Blaney, Susan M.


Book ID
121704814
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
79 KB
Volume
61
Category
Article
ISSN
1545-5009

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase 2 study of temozolomide in childre
โœ H. Stacy Nicholson; Cynthia S. Kretschmar; Mark Krailo; Mark Bernstein; Richard ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. ## METHODS. Temozolomide was ad

Phase II investigation of docetaxel in p
โœ Ted Zwerdling; Mark Krailo; Philip Monteleone; Rebecca Byrd; Judith Sato; Rose D ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND Docetaxel, which is an antitubulin agent, has demonstrable activity against murine and human tumors. The current study was designed to determine response rates to docetaxel in various strata of recurrent solid tumors of childhood and to assess toxicity in a group of patie